| 000 | 01913 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518072851.0 | ||
| 264 | 0 | _c20210507 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1473-1150 | ||
| 024 | 7 |
_a10.1038/s41397-019-0127-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOz, Merve Demirbugen | |
| 245 | 0 | 0 |
_aAssociation between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. _h[electronic resource] |
| 260 |
_bThe pharmacogenomics journal _c06 2020 |
||
| 300 |
_a443-450 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xgenetics |
| 650 | 0 | 4 |
_aCitalopram _xadverse effects |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2A _xgenetics |
| 650 | 0 | 4 |
_aSerotonin Plasma Membrane Transport Proteins _xgenetics |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aSertraline _xadverse effects |
| 650 | 0 | 4 |
_aSexual Dysfunction, Physiological _xchemically induced |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBaskak, Bora | |
| 700 | 1 | _aUckun, Zuhal | |
| 700 | 1 | _aArtun, Nazan Yuce | |
| 700 | 1 | _aOzdemir, Hatice | |
| 700 | 1 | _aOzel, Tugba Kizil | |
| 700 | 1 | _aOzguven, Halise Devrimci | |
| 700 | 1 | _aSuzen, H Sinan | |
| 773 | 0 |
_tThe pharmacogenomics journal _gvol. 20 _gno. 3 _gp. 443-450 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41397-019-0127-8 _zAvailable from publisher's website |
| 999 |
_c30376763 _d30376763 |
||